| Name | Title | Contact Details |
|---|
Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.
The i/mx Companies is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mitchell County Hospital Health Systems is a regional hospital located in Beloit, Kansas that serves North Central Kansas patients and communities with exceptional healthcare in a compassionate and healing environment.
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Data R X Management is a Cumming, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.